TLR4 and neoplasm: Furthermore, studies have also shown that TLR4 ligands serve as potent immune adjuvants in aggressive malignancies, and TLR4 in most tumor cells (including UCEC) can change the tumor microenvironment to escape immune surveillance, while activated TLR4 can also enhance the immune response and produce anti-tumor effects (45).